{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:39:06Z","timestamp":1783600746127,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.bcp.2021.114436","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T12:32:43Z","timestamp":1612269163000},"page":"114436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Eltrombopag inhibits Type I interferon-mediated antiviral signaling by decreasing cellular iron"],"prefix":"10.1016","volume":"186","author":[{"given":"Sai","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nailin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7301-1833","authenticated-orcid":false,"given":"Zi","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2021.114436_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2010.01366.x","article-title":"Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review","volume":"18","author":"Louie","year":"2011","journal-title":"J. Viral Hepat."},{"issue":"22","key":"10.1016\/j.bcp.2021.114436_b0010","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"issue":"9763","key":"10.1016\/j.bcp.2021.114436_b0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(10)60959-2","article-title":"Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study","volume":"377","author":"Cheng","year":"2011","journal-title":"The Lancet"},{"issue":"22","key":"10.1016\/j.bcp.2021.114436_b0020","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","article-title":"Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C","volume":"357","author":"McHutchison","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcp.2021.114436_b0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.med.60.042307.181154","article-title":"Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia","volume":"60","author":"Kuter","year":"2009","journal-title":"Annu. Rev. Med."},{"issue":"2","key":"10.1016\/j.bcp.2021.114436_b0030","first-page":"92","article-title":"Cytokines, STATs and liver disease","volume":"2","author":"Gao","year":"2005","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114436_b0035","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in HCV infections","volume":"61","author":"Heim","year":"2014","journal-title":"J. Hepatol."},{"issue":"14","key":"10.1016\/j.bcp.2021.114436_b0040","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00018-017-2520-2","article-title":"Advances in anti-viral immune defence: revealing the importance of the IFN JAK\/STAT pathway","volume":"74","author":"Raftery","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.bcp.2021.114436_b0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"10003","key":"10.1016\/j.bcp.2021.114436_b0050","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bcp.2021.114436_b0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bpg.2017.04.012","article-title":"Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon","volume":"31","author":"Ghany","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114436_b0060","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","article-title":"Thrombopoietin receptor agonists: ten years later","volume":"104","author":"Ghanima","year":"2019","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bcp.2021.114436_b0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2003.05.001","article-title":"AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl","volume":"25","author":"Broudy","year":"2004","journal-title":"Cytokine"},{"issue":"17","key":"10.1016\/j.bcp.2021.114436_b0070","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2016-10-740241","article-title":"Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator","volume":"130","author":"Vlachodimitropoulou","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2021.114436_b0075","doi-asserted-by":"crossref","unstructured":"M. Roth, B. Will, G. Simkin, S. Narayanagari, L. Barreyro, B. Bartholdy, R. Tamari, C.S. Mitsiades, A. Verma, U. Steidl, Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation, Blood 120(2) (2012) 386\u2013394.","DOI":"10.1182\/blood-2011-12-399667"},{"issue":"458","key":"10.1016\/j.bcp.2021.114436_b0080","doi-asserted-by":"crossref","first-page":"eaas9563","DOI":"10.1126\/scitranslmed.aas9563","article-title":"Thrombopoietin receptor\u2013independent stimulation of hematopoietic stem cells by eltrombopag","volume":"10","author":"Kao","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2021.114436_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exphem.2020.04.006","article-title":"Signaling properties of murine MPL and MPL mutants after stimulation with thrombopoietin and romiplostim","volume":"85","author":"Rommel","year":"2020","journal-title":"Exp. Hematol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114436_b0090","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.stem.2007.10.020","article-title":"Thrombopoietin\/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche","volume":"1","author":"Yoshihara","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bcp.2021.114436_b0095","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.jhep.2016.01.028","article-title":"The role of innate immunity in the immunopathology and treatment of HBV infection","volume":"64","author":"Maini","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2021.114436_b0100","doi-asserted-by":"crossref","unstructured":"X.-g. Liu, S. Liu, Q. Feng, X.-n. Liu, G.-s. Li, Z. Sheng, P. Chen, Y. Liu, Y. Wei, X.-y. Dong, P. Qin, C. Gao, C. Ma, L. Zhang, M. Hou, J. Peng, Thrombopoietin receptor agonists shift the balance of Fc\u03b3 receptors toward inhibitory receptor IIb on monocytes in ITP, Blood 128(6) (2016) 852\u2013861.","DOI":"10.1182\/blood-2016-01-690727"},{"issue":"6","key":"10.1016\/j.bcp.2021.114436_b0105","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2021.114436_b0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/cmi.2013.70","article-title":"An unbalanced PD-L1\/CD86 ratio in CD14(++)CD16(+) monocytes is correlated with HCV viremia during chronic HCV infection","volume":"11","author":"Zheng","year":"2014","journal-title":"Cell. Mol. Immunol."},{"issue":"16","key":"10.1016\/j.bcp.2021.114436_b0115","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2012-06-434605","article-title":"CD16+ monocytes control T-cell subset development in immune thrombocytopenia","volume":"120","author":"Zhong","year":"2012","journal-title":"Blood"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2021.114436_b0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2008.02.060","article-title":"Characterization of novel non-peptide thrombopoietin mimetics, their species specificity and the activation mechanism of the thrombopoietin receptor","volume":"586","author":"Yamane","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114436_b0125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/stemcells.2008-0366","article-title":"Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist","volume":"27","author":"Erickson-Miller","year":"2009","journal-title":"Stem Cells"},{"issue":"31","key":"10.1016\/j.bcp.2021.114436_b0130","doi-asserted-by":"crossref","first-page":"12764","DOI":"10.1074\/jbc.R117.791962","article-title":"Cytosolic iron chaperones: proteins delivering iron cofactors in the cytosol of mammalian cells","volume":"292","author":"Philpott","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114436_b0135","doi-asserted-by":"crossref","unstructured":"G. Giannuzzi, P.J. Schmidt, E. Porcu, G. Willemin, K.M. Munson, X. Nuttle, R. Earl, J. Chrast, K. Hoekzema, D. Risso, K. Mannik, P. De Nittis, E.D. Baratz, C. p, Y. Herault, X. Gao, C.C. Philpott, R.A. Bernier, Z. Kutalik, M.D. Fleming, E.E. Eichler, A. Reymond, The human-specific BOLA2 duplication modifies iron homeostasis and anemia predisposition in chromosome 16p11.2 autism individuals, Am. J. Hum. Genet. 105(5) (2019) 947\u2013958.","DOI":"10.1016\/j.ajhg.2019.09.023"},{"key":"10.1016\/j.bcp.2021.114436_b0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcp.2019.06.017","article-title":"Enterobactin, an iron chelating bacterial siderophore, arrests cancer cell proliferation","volume":"168","author":"Saha","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"18","key":"10.1016\/j.bcp.2021.114436_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201900220","article-title":"Fenton-chemistry-mediated radical polymerization","volume":"40","author":"Reyhani","year":"2019","journal-title":"Macromol. Rapid Commun."},{"issue":"6","key":"10.1016\/j.bcp.2021.114436_b0150","doi-asserted-by":"crossref","first-page":"C1640","DOI":"10.1152\/ajpcell.1998.275.6.C1640","article-title":"Activation of the JAK-STAT pathway by reactive oxygen species","volume":"275","author":"Simon","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114436_b0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.vph.2005.08.018","article-title":"Hyperglycemia and reactive oxygen species mediate apoptosis in aortic endothelial cells through Janus kinase 2","volume":"43","author":"Tawfik","year":"2005","journal-title":"Vasc. Pharmacol."},{"issue":"13","key":"10.1016\/j.bcp.2021.114436_b0160","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/glia.20542","article-title":"Exposure of glia to pro-oxidant agents revealed selective Stat1 activation by H2O2 and Jak2-independent antioxidant features of the Jak2 inhibitor AG490","volume":"55","author":"Gorina","year":"2007","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.bcp.2021.114436_b0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1471-4159.2004.02878.x","article-title":"AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2\/STAT pathway","volume":"92","author":"Gorina","year":"2005","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.bcp.2021.114436_b0170","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of Type I and Type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bcp.2021.114436_b0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/cmi.2014.127","article-title":"Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection","volume":"13","author":"Wong","year":"2016","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114436_b0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000353220","article-title":"Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication","volume":"6","author":"Pei","year":"2014","journal-title":"J. Innate Immun."},{"issue":"17","key":"10.1016\/j.bcp.2021.114436_b0185","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1016\/j.jmb.2016.04.032","article-title":"Interferon-inducible GTPases in host resistance, inflammation and disease","volume":"428","author":"Pilla-Moffett","year":"2016","journal-title":"J. Mol. Biol."},{"issue":"1 Suppl 2","key":"10.1016\/j.bcp.2021.114436_b0190","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminhematol.2008.12.005","article-title":"Pathobiology of secondary immune thrombocytopenia","volume":"46","author":"Cines","year":"2009","journal-title":"Semin. Hematol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114436_b0195","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.83.6.1627","article-title":"Hepatitis B virus DNA contains a glucocorticoid-responsive element","volume":"83","author":"Tur-Kaspa","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.bcp.2021.114436_b0200","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.2007.08058.x","article-title":"Chronic hepatitis B reactivation: a word of caution regarding the use of systemic glucocorticosteroid therapy","volume":"157","author":"Yang","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114436_b0205","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s00535-012-0600-5","article-title":"Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study","volume":"47","author":"Kawaguchi","year":"2012","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bcp.2021.114436_b0210","doi-asserted-by":"crossref","unstructured":"N.H. Afdhal, G.M. Dusheiko, E.G. Giannini, P.J. Chen, K.H. Han, A. Mohsin, M. Rodriguez-Torres, S. Rugina, I. Bakulin, E. Lawitz, M.L. Shiffman, G.U. Tayyab, F. Poordad, Y.M. Kamel, A. Brainsky, J. Geib, S.Y. Vasey, R. Patwardhan, F.M. Campbell, D. Theodore, Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy, Gastroenterology 146(2) (2014) 442-52 e1.","DOI":"10.1053\/j.gastro.2013.10.012"},{"issue":"26","key":"10.1016\/j.bcp.2021.114436_b0215","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","article-title":"Disorders of iron metabolism","volume":"341","author":"Andrews","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.bcp.2021.114436_b0220","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nri3863","article-title":"Iron homeostasis in host defence and inflammation","volume":"15","author":"Ganz","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"10116","key":"10.1016\/j.bcp.2021.114436_b0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","article-title":"Thalassaemia","volume":"391","author":"Taher","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bcp.2021.114436_b0230","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2015-08-663245","article-title":"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease","volume":"127","author":"Vinchi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2021.114436_b0235","doi-asserted-by":"crossref","unstructured":"I. Theurl, V. Mattle, M. Seifert, M. Mariani, C. Marth, G.n. Weiss, Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease, Blood 107(10) (2006) 4142\u20134148.","DOI":"10.1182\/blood-2005-08-3364"},{"issue":"6","key":"10.1016\/j.bcp.2021.114436_b0240","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ. Res."},{"issue":"18","key":"10.1016\/j.bcp.2021.114436_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184659","article-title":"Effect of hepatitis viruses on the Nrf2\/Keap1-signaling pathway and its impact on viral replication and pathogenesis","volume":"20","author":"Bender","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:26:02Z","timestamp":1757769962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":49,"alternative-id":["S0006295221000320"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114436","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eltrombopag inhibits Type I interferon-mediated antiviral signaling by decreasing cellular iron","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114436"}}